Back to results
US 2014/0155401 A1Published application
Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
AssigneeBayer Intellectual Property GmbH
InventorsPeter NELL, Walter Hübsch, Barbara ALBRECHT-KÜPPER, Jörg KELDENICH, Andreas KNORR
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel substituted 2,4′- and 3,4′-bipyridine derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of hypertension and other cardiovascular disorders.
Claims17
A compound of formula (I)
- wherein
- one of the two ring members X and Y represents N and the other represents C—R6, where
- R6 represents hydrogen or (C1-C4)-alkyl,
- Z represents N—R7 or O, where
- R7 represents hydrogen or (C1-C4)-alkyl which may be substituted by hydroxyl or (C1-C4)-alkoxy,
- R1 and R2 are identical or different and independently of one another represent hydrogen or (C1-C6)-alkyl which may be mono- or disubstituted by identical or different substituents from a group consisting of hydroxyl, (C1-C4)-alkoxy, amino, mono-(C1-C4)-alkylamino, di-(C1-C4)-alkylamino, carboxyl, (C1-C4)-alkoxycarbonyl and a 4- to 7-membered heterocycle,
- where the heterocycle mentioned contains one or two ring heteroatoms from the group consisting of N, O and S and for its part may be mono- or disubstituted by identical or different substituents from the group consisting of (C1-C4)-alkyl, hydroxyl, oxo and (C1-C4)-alkoxy,
- or
- R1 and R2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further ring heteroatom from the group consisting of N, O and S and which may be mono- or disubstituted by identical or different substituents from the group consisting of (C1-C4)-alkyl, hydroxyl, oxo and (C1-C4)-alkoxy,
- R3 represents hydrogen or (C1-C6)-alkyl which may be mono- or disubstituted by identical or different substituents from the group consisting of (C3-C6)-cycloalkyl, oxo, hydroxyl, (C1-C4)-alkoxy, carboxyl, amino, mono-(C1-C4)-alkylamino and di-(C1-C4)-alkylamino, or represents (C4-C6)-cycloalkyl,
- where the cycloalkyl radicals mentioned for their part may be substituted up to two times by identical or different substituents from the group consisting of (C1-C4)-alkyl, hydroxyl, oxo and (C1-C4)-alkoxy and where in these cycloalkyl radicals a ring CH2-group may be replaced by an oxygen atom,
- R4 represents hydrogen, halogen, (C1-C4)-alkyl or (C1-C4)-alkoxy, where alkyl and alkoxy may each be substituted up to three times by fluorine,
- and
- R5 represents 5 to 10-membered heteroaryl having up to three ring heteroatoms from the group consisting of N, O and S, which may in each case
- (i) be mono- or disubstituted by identical or different substituents from the group consisting of halogen, nitro, cyano, (C1-C6)-alkyl, phenyl, hydroxyl, (C1-C6)-alkoxy, amino, mono-(C1-C6)-alkylamino, mono-(C2-C6)-alkenylamino and di-(C1-C6)-alkylamino
- and/or
- (ii) be substituted by pyrrolidino, piperidino, morpholino, piperazino, N′—(C1-C4)-alkylpiperazino or a group of the formula -L-R8, where
- L represents a bond, NH or O
- and
- R8 represents phenyl or 5- or 6-membered heteroaryl having up to three ring heteroatoms from the group consisting of N, O and S, each of which may be mono- to trisubstituted by identical or different substituents from the group consisting of halogen, nitro, cyano, (C1-C6)-alkyl, trifluoromethyl, hydroxyl, (C1-C6)-alkoxy, difluoromethoxy, trifluoromethoxy, amino, mono-(C1-C6)-alkylamino, di-(C1-C6)-alkylamino, (C1-C6)-alkoxycarbonyl and carboxyl,
- or a salt thereof.
18 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.